Target Price Updates on Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Mirati Therapeutics, Inc. (NASDAQ:MRTX)

Equity Research firms currently have a positive stance on shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.90. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $18.33 on a short term basis.

At the time of writing, the stock was trading at $18.30. This represents a change from most recent open price of 7.02%. In terms of performance, year to date, the stock is 11.59%. The monthly stock performance comes in at 13.66%. For the quarter, shares are performing at 15.09%. Weekly performance analysis shows the equity at 6.40%.

In taking a look at technical levels, shares are trading 19.35% away from the 50 day simple moving average and 67.08% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -2.11% away from it’s 52- week high and 446.27% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Sangamo Therapeutics, Inc.’s RSI stands at 65.19. In looking at volatility levels, the shares saw weekly volatility of 5.43% and 5.67% over the past month.

Sell-side analysts are offering a consensus “Buy” rating on shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.70.  Based on a recent trade, the shares are hovering around $24.75 which, according to analysts, yield significant upside potential to the $17.86 consensus target price.

Mirati Therapeutics, Inc. (NASDAQ:MRTX) shares typically trade an average volume of 454.18 and institutions hold 79.60% of the total shares.  


We see here that the stock is 34.53% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of 47.62% from current levels.  Further back, their 200-Day Simple Moving Average is 181.98% difference from today’s price.  Currently, the stock is 5.54% from its 50-Day High and 97.21% from the 50-day low. 

Mirati Therapeutics, Inc. (NASDAQ:MRTX)‘s stock has performed at 35.62%.  Breaking that down further, it has performed 32.35% for the week, 55.66% for the month, 74.91% over the last quarter, 534.62% for the past half-year and 354.13% for this last year. 

Leave a Comment